| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |